These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35034026)

  • 1. Prognostic Potential of METTL7B in Glioma.
    Fu R; Luo X; Ding Y; Guo S
    Neuroimmunomodulation; 2022; 29(3):186-201. PubMed ID: 35034026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma.
    Luo C; Wang S; Shan W; Liao W; Zhang S; Wang Y; Xin Q; Yang T; Hu S; Xie W; Xu N; Zhang Y
    Front Immunol; 2022; 13():909189. PubMed ID: 35769464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma.
    Mei J; Cai Y; Xu R; Yang X; Zhou W; Wang H; Liu C
    Technol Cancer Res Treat; 2021; 20():15330338211011970. PubMed ID: 33955303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.
    Jiang Z; Yin W; Zhu H; Tan J; Guo Y; Xin Z; Zhou Q; Cao Y; Wu Z; Kuang Y; Li C; Xie D; Huang H; Zhao M; Jiang X; Wang L; Ren C
    Cancer Cell Int; 2021 Jul; 21(1):383. PubMed ID: 34281539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma.
    Xiong Y; Li M; Bai J; Sheng Y; Zhang Y
    Front Oncol; 2021; 11():650534. PubMed ID: 33996568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.
    Cheng X; Liu Z; Liang W; Zhu Q; Wang C; Wang H; Zhang J; Li P; Gao Y
    Int J Biochem Cell Biol; 2023 May; 158():106409. PubMed ID: 36997057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma.
    Chen X; Li C; Li Y; Wu S; Liu W; Lin T; Li M; Weng Y; Lin W; Qiu S
    Front Mol Biosci; 2021; 8():727481. PubMed ID: 34604305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
    Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
    J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma.
    Wang X; Huang Y; Li S; Zhang H
    Front Immunol; 2022; 13():1027154. PubMed ID: 36275754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
    Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the prognostic potential of m6A methylation regulators in low-grade glioma: implications for tumor microenvironment modulation.
    Wu H; Chen S; Hu Z; Ge R; Ma L; You C; Huang Y
    Eur J Med Res; 2024 Jan; 29(1):19. PubMed ID: 38173044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis.
    Zhao C; Zhang N; Cui X; Zhang X; Ren Y; Su C; He J; Zhang W; Sun X; Yang J; Gao X
    Cancer Med; 2021 Apr; 10(8):2826-2839. PubMed ID: 33713047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
    Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
    Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.
    Luo H; Tao C; Long X; Huang K; Zhu X
    Aging (Albany NY); 2021 Jun; 13(12):16198-16218. PubMed ID: 34114970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.